Pharmaceutical

Elpiscience and Astellas partner for new macrophage engagers

Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new bispecific macrophage engagers for cancer.

Dec 28, 2023 - 18:00
Elpiscience and Astellas partner for new macrophage engagers
Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new bispecific macrophage engagers for cancer.
Read the original article

Tags:

Previous Article

J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem

Next Article

ARTBIO divulges plans for proprietary isotope manufacturing technology

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Hospitals pledge to protect patient privacy. Almost all their websites leak visitor data like a sieve

Hospitals pledge to protect patient privacy. Almost all...

Apr 3, 2023

Opinion: How the twin crises of climate change and poor public housing are harming people’s health

Opinion: How the twin crises of climate change and poor...

Aug 29, 2023

STAT+: At JPM, Bristol’s new CEO appeals to history to try to soothe investors’ nerves

STAT+: At JPM, Bristol’s new CEO appeals to history to ...

Jan 8, 2024